| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.8B | $0.6B | $0.5B | $1.1B | $0.9B | $0.5B | $0.7B | $0.6B |
| EPS (Basic) | $12.31 | $8.56 | $7.53 | $14.65 | $11.49 | $5.88 | $6.89 | $6.07 |
| EPS (Diluted) | $12.30 | $8.56 | $7.52 | $14.63 | $11.46 | $5.87 | $6.88 | $6.06 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $75.3B | $73.0B | $70.8B | $67.6B | $75.1B | $65.9B | $52.1B | $47.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $69.1B | $67.4B | $65.6B | $63.5B | $69.1B | $59.9B | $46.1B | $42.2B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.2B | $5.6B | $5.1B | $4.1B | $6.0B | $6.0B | $6.0B | $5.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $0.7B | $0.7B | $1.0B | $1.0B | $0.7B | $0.7B | $0.8B |
| Investing Cash Flow | $-1.8B | $-1.6B | $-2.6B | $5.4B | $-10.5B | $-13.1B | $-4.2B | $-4.4B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $0.9B | $1.0B | $1.9B | $-6.3B | $9.5B | $12.5B | $3.5B | $3.5B |